Home > Boards > US Listed > Biotechs > iBio, Inc. (IBIO)

Well, everything you've mentioned is forum and newsletter

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Mokyo Toe Member Profile
 
Followed By 29
Posts 1,990
Boards Moderated 0
Alias Born 01/02/08
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/12/2021 4:06:37 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 1/11/2021 5:20:53 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 1/11/2021 5:20:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/28/2020 8:01:27 AM
iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer GlobeNewswire Inc. - 12/28/2020 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/23/2020 4:32:04 PM
iBio Announces Closing of its Public Offering of Common Stock GlobeNewswire Inc. - 12/10/2020 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2020 4:33:55 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/9/2020 4:27:50 PM
iBio Announces Pricing of $35 Million Public Offering of Common Stock GlobeNewswire Inc. - 12/8/2020 8:55:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 12/8/2020 6:02:40 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/7/2020 4:20:08 PM
iBio Announces Proposed Public Offering of Common Stock GlobeNewswire Inc. - 12/7/2020 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/7/2020 8:35:46 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/2/2020 5:25:52 PM
iBio Selected to Produce ATB Therapeutics’ Bioengineered Antibody-Toxin Fusion Proteins GlobeNewswire Inc. - 12/1/2020 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/25/2020 5:11:22 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 11/25/2020 4:39:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/24/2020 7:41:08 AM
iBio Announces Issuance of U.S. Patent Covering Endostatin Peptides for Treating Fibrosis GlobeNewswire Inc. - 11/24/2020 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/16/2020 4:18:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 4:11:59 PM
iBio Reports Fiscal First Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 11/16/2020 4:05:00 PM
iBio to Participate in Alliance Global Partners’ Virtual Healthcare Symposium GlobeNewswire Inc. - 11/12/2020 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/6/2020 4:03:51 PM
Mokyo Toe   Tuesday, 01/13/15 10:25:31 PM
Re: Diaz83 post# 13351
Post # of 25588 
Well, everything you've mentioned is forum and newsletter hype, not real DD.

Some realities:

1. The company made less in revenue in the past year than a typical pediatrician earns, and spent twenty times that much.
2. The Gates Foundation is not "sponsoring this stock" and never has.
3. The company does not produce vaccines.
4. There are no real institutional investors. Vanguard only holds shares for its index fund, as it does with every stock that trades on the exchange.
5. The whole Ebola connection was fabricated.
6. The Ebola pump and dump is unwinding.
7. Dilution on the horizon.
8. Lawsuits on the horizon.

Frankly, the only reason why the stock is still up so high at .46 is because those who bought in on message board hype haven't done the 20 minutes of DD it takes to verify all of the above, and haven't dumped their shares yet. They will. This is a good candidate to fall below ten cents in the months ahead. Imho, of course.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences